A selection of articles related to rifampicin indications.
Original articles from our library related to the Rifampicin Indications. See Table of Contents for further available material (downloadable resources) on Rifampicin Indications.
- Valerian Root, All About
- True Wild Valerian Root, Valeriana officinalis The name "Valerian" is derived from the Latin valere , which means "to be strong" and refers to both the health benefits of the plant as well as its distinct odor. The plant was known as "...
Herbalism >> Herbs dictionary V
- Survivalists' Guide for the New Millennium: Chapter 2
- WORKING TO LIVE RATHER THAN LIVING TO WORK Before the dawn of recorded history, a major period of transition occurred. Nomadic hunter-gatherer clans transformed themselves into larger communities who farmed the land. This they did by planting their own...
Philosophy >> Survivalists Guide for the New Millennium
Rifampicin Indications is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Rifampicin Indications books and related discussion.
Suggested News Resources
- This Disease Could Kill 75 Million People By 2050, And You've Likely Never
- But two similar action plans on MDR-TB, released by the U.S. Centers for Disease Control and Prevention in 1992 and 2009, never received the money they needed, and there's little indication this measure will, either.
- Boehringer Ingelheim's Gilotrif® (afatinib) demonstrated superiority to Iressa
- Approval of afatinib in this indication was based on the primary endpoint of PFS from the LUX-Lung 3 clinical trial where afatinib significantly delayed tumor growth when compared to standard chemotherapy.
- Murder at The Hague? The strange case of sick & suicidal Serbs
- However, a tribunal registrar did confirm that traces of rifampicin, a tasteless, odorless drug which can easily be administered in food without the subject knowing anything about it, was found in Milosevic's blood in a test on 12th January.
- FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to
- Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma ...